List of Studies ( Metabolite:PE 39:2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST003291 | AN005390 | Atopic dermatitis and STAT3 double null mutant skin biopsies during healing. | Skin | Human | Eczema | National Institutes of Health | MALDI-MS |
| ST003160 | AN005184 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003051 | AN005002 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST003051 | AN005003 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002309 | AN003771 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002108 | AN003448 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002107 | AN003446 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001315 | AN002189 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001292 | AN002150 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000779 | AN001232 | Lipidomics pilot project for mice exposure to bisphenol A and high fat diets | Blood | Mouse | Fatty liver disease | University of Michigan | LC-MS |
| ST000685 | AN001056 | Lipidomics analysis for human liver cell lines | Cultured cells | Human | University of Michigan | LC-MS | |
| ST000680 | AN001046 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part III | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000679 | AN001044 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000678 | AN001042 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000665 | AN001016 | Nonalcoholic fatty liver disease (NAFLD) Studies | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Rat | Obesity | University of Michigan | LC-MS |